Chemed Corporation $CHE Stake Raised by Principal Financial Group Inc.

Principal Financial Group Inc. raised its holdings in Chemed Corporation (NYSE:CHEFree Report) by 3.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,598 shares of the company’s stock after acquiring an additional 1,135 shares during the quarter. Principal Financial Group Inc. owned 0.24% of Chemed worth $11,936,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in CHE. Monetary Solutions Ltd acquired a new stake in Chemed during the fourth quarter valued at approximately $25,000. Los Angeles Capital Management LLC bought a new stake in Chemed during the fourth quarter worth approximately $26,000. BOK Financial Private Wealth Inc. acquired a new position in Chemed in the fourth quarter worth approximately $27,000. Global Retirement Partners LLC grew its position in Chemed by 200.0% in the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after buying an additional 58 shares during the last quarter. Finally, Rothschild Investment LLC increased its holdings in shares of Chemed by 800.0% in the fourth quarter. Rothschild Investment LLC now owns 108 shares of the company’s stock valued at $46,000 after buying an additional 96 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on CHE shares. Royal Bank Of Canada increased their price objective on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research report on Monday, April 27th. Wall Street Zen cut Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Bank of America boosted their target price on Chemed from $450.00 to $510.00 and gave the stock a “neutral” rating in a research report on Thursday, July 9th. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Finally, Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $480.25.

View Our Latest Analysis on CHE

Insiders Place Their Bets

In other news, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the sale, the director owned 4,578 shares of the company’s stock, valued at $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. This trade represents a 2.17% decrease in their position. The disclosure for this sale is available in the SEC filing. 3.33% of the stock is owned by corporate insiders.

Chemed Stock Up 1.4%

CHE stock opened at $510.28 on Friday. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. The firm has a market capitalization of $6.77 billion, a P/E ratio of 27.81, a P/E/G ratio of 1.85 and a beta of 0.52. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $517.74. The company’s 50 day simple moving average is $458.59 and its 200-day simple moving average is $433.65.

Chemed (NYSE:CHEGet Free Report) last posted its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The firm had revenue of $657.51 million during the quarter, compared to analyst estimates of $659.22 million. During the same quarter last year, the business posted $5.63 EPS. The company’s revenue was up 1.6% on a year-over-year basis. As a group, equities research analysts anticipate that Chemed Corporation will post 22.67 EPS for the current year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were issued a $0.60 dividend. The ex-dividend date was Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. Chemed’s dividend payout ratio is presently 13.08%.

Chemed Profile

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Featured Articles

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.